Become the Professional Who Keeps Medicines Safe
Pharmacovigilance is the discipline that catches a drug’s hidden risks once it reaches patients. PharmaLink’s six-month Drug Safety Capability Pathway takes healthcare and life-sciences professionals into the work itself — real adverse-event cases, real signal detection, real aggregate reports — inside VIGILANT™, our simulated safety database environment. You leave with evidence you can do the job, not a certificate saying you attended a course.
No prior pharma experience requiredWhat Drug Safety Professionals Actually Do
Every medicine in use worldwide generates safety data from real patients. Pharmacovigilance is the discipline that collects, evaluates, and acts on that data — and the drug safety professional is the person who turns signals into decisions.
PV professionals process adverse-event reports, detect emerging safety signals, and write the aggregate reports (PSURs, PBRERs, DSURs) that regulators like the MHRA, EMA, and FDA use to monitor a drug’s ongoing benefit-risk balance. Without this work, unsafe medicines stay on the market. That’s why drug safety is one of the most regulated and fastest-growing functions in pharma.
Drug safety professionals collaborate daily with medical reviewers, regulatory affairs, clinical teams, and marketing authorisation holders. The role demands precision under ICH-GVP rules, scientific judgement on causality and expectedness, and the ability to meet hard regulatory deadlines — 7-day expedited, 15-day serious, and periodic reporting cycles.
Case Processing
Process ICSRs to ICH-GVP standards with correct MedDRA coding, causality, and expectedness assessment.
Signal Intelligence
Detect, validate, and evaluate safety signals that could change a drug’s risk profile.
Cross-Functional Impact
Work with medical, regulatory, and clinical teams to keep benefit-risk current on every marketed product.
The Documents You’ll Master
You will work hands-on with the exact outputs pharmacovigilance teams produce every day inside VIGILANT™, our simulated safety database:
ICSRs — Individual Case Safety Reports
The core unit of pharmacovigilance — adverse-event cases coded, assessed, and submitted within regulatory deadlines.
PSURs — Periodic Safety Update Reports
Aggregate safety reviews that keep a drug’s benefit-risk current for every regulator worldwide.
DSURs — Development Safety Update Reports
Annual safety summaries for drugs still in clinical development, submitted to EMA, FDA and MHRA.
PBRERs — Benefit-Risk Evaluation
ICH E2C(R2) aggregate reports weighing a marketed product’s cumulative benefits against its risks.
Signal Detection & Evaluation
Identify, validate, and prioritise emerging safety signals using EudraVigilance, FAERS, and literature review.
Risk Management Plans (RMPs)
Plan how each product’s identified and potential risks are monitored, minimised, and communicated post-approval.
You won’t just learn what these reports are. You’ll process, draft, and review them — inside VIGILANT™, our simulated safety database, to ICH-GVP standards with expert review at every stage.
Two phases. Six months. Industry-grade by the end.
The programme moves from operational foundation to applied practice. By the time you finish, you have a portfolio of regulatory-grade PV deliverables reviewed by senior pharmacovigilance experts — the kind of evidence that opens interview doors.
Foundations
Weeks 1–12
Build the operational pharmacovigilance foundation.
Twelve weeks getting fluent in the languages of pharmacovigilance — GVP modules, ICH E2 guidelines, case processing workflows — and the contexts they live inside.
- Regulatory frameworks — ICH-GVP, FDA, MHRA, EMA, CIOMS
- The full safety landscape — ICSRs, PSURs, PBRERs, DSURs, RMPs
- Case intake and ICSR workflows — E2B(R3) formats, expedited and periodic reporting timelines
- MedDRA coding, causality assessment, seriousness and expectedness judgements
- Reading clinical outputs through a safety lens — AEs, SAEs, SUSARs, reference safety information
Applied Portfolio
Weeks 13–26
Work the live database. Get reviewed by senior PV experts. Build the evidence.
The second half of the programme is applied. You work inside VIGILANT™, our simulated safety database, processing real adverse-event cases and drafting aggregate reports, each reviewed and marked up by a senior pharmacovigilance expert. By week 26 you have a portfolio you can put in front of an interviewer.
- ICSR case series processed inside VIGILANT™ — MedDRA-coded, causality-assessed, expedited and non-expedited
- Signal detection exercise using EudraVigilance-style extracts — identify, validate, prioritise
- PSUR/PBRER section drafted from aggregate safety data, including benefit-risk narrative
- One advanced deliverable scoped to your direction (e.g. RMP section, DSUR chapter, literature-screening write-up)
- Senior PV expert review on every output, with iteration cycles modelled on industry practice
What's Included
Everything you need to walk into a pharmacovigilance role.
One programme fee. 6 months of teaching, expert review and portfolio building. Three payment options designed to make the transition affordable.
What's included in your seat
Live evening sessions, once weekly (6–8pm)
Taught by industry pharmacovigilance experts across the full six months — never pre-recorded.
Portfolio of PV deliverables
You leave with expert-reviewed examples of core PV deliverables — ICSR case series, PSUR/PBRER section, signal detection exercise, and one advanced scoped output.
Senior PV expert review on every deliverable
Your work is reviewed one-to-one by senior pharmacovigilance experts — the same peer-review process PV teams run internally. Track-change comments, line-by-line critique, iteration rounds. You learn how real safety outputs actually get shaped.
Career support & job-search coaching
CV review, interview prep, and guidance on positioning your portfolio for pharmacovigilance roles.
CPD-accredited certificate of completion
Recognised across the UK pharmaceutical industry. Adds to your CPD record.
Lifetime access to course materials
Recordings and written materials — yours to revisit when you start in role.
VIGILANT™ — our simulated safety database — is included with every seat for the full six months.
Programme Fee
£3,999
Base programme · 6 months · 8–10 hours per week · 2 cohorts every month
Pay outright
£3,999 in full at enrolment.
3-month plan
3 × £1,333, monthly.
12-month finance
Third-party finance plan, subject to eligibility.
Two entry points. One Pharmacovigilance career.
Start with the foundations if you’re new to pharmacovigilance. Take the full path if you’re committing to the signal-management, aggregate-reporting, and inspection-readiness work that leads into PV Scientist and PV Manager roles.
The entry route into industry PV. Enough to stand up Drug Safety Associate work with confidence.
- ICSR case processing
- MedDRA coding
- Narrative writing
- Quality and documentation
- Basic signal detection
- VIGILANT™ database access for the full 8 weeks
- Career support and job-search coaching
The full path. Covers everything in Tier 1, then takes you into Signal Scientist and PV Manager territory.
- Everything in Tier 1
- Signal assessment
- Signal detection and validation
- Literature review
- DSUR, PBRER and RMP authoring
- CAPA, audits and inspection readiness
- VIGILANT™ database access for the full 6 months
Not sure which tier fits? Book a 20-minute discovery call and we’ll tell you honestly.
Career & Salary Outlook
Pharmacovigilance pays — and it compounds.
UK salary bands for pharmacovigilance roles across industry, CROs, and consultancies. Ranges reflect typical base (excluding bonus and benefits) in 2026.
Entry
£25–50k
Drug Safety Associate
Case intake, ICSR processing, MedDRA coding, expedited reporting. Foundation role across pharma, CROs and consultancies.
Mid
£35–60k
PV Scientist / Signal Associate
Signal detection and evaluation, aggregate report contributions (PSUR/PBRER), medical review, RMP input. Hands-on ownership of safety output.
Senior
£55–90k
Signal Scientist / PV Manager
Signal strategy, aggregate report lead, RMP authoring and lifecycle, safety governance, audit/inspection readiness, team line-management.
Typical Career Path
Drug Safety Associate → PV Scientist → Signal Scientist → PV Manager
Salary ranges are UK market indicators, not guarantees. Progression depends on experience, specialisation (e.g. oncology, biologics) and employer type.
From the PharmaLink Alumni Community
Graduates doing the work — in their own words. PV cohort 1 stories publish June 2026.
Walking into my first sponsor meeting as a regulatory writer, I realised I'd already done this exact thing inside FORGE™. Same pressure, same questions. I wasn't learning the job — I was continuing it.
I'd been an NHS pharmacist for eleven years and wasn't sure a pivot was even possible. Six months in, I was offered a writing role. The portfolio they asked to see — I already had it.
What made PharmaLink different was how seriously they treated the transition. No slides on 'what is a CSR.' You write one. Then another. Then you defend it to someone who's actually written them for a living.
The coaching in Phase 2 was what set it apart. Direct, specific, industry-calibrated. You knew the feedback you were getting was the same feedback a line manager would give.
430+ graduates · 69% placed into pharma roles post-completion
Who This Is For
Built for career-switchers, scientists, and Drug Safety Associates ready to go deeper.
If you have a science background and want a career in pharmacovigilance — or you’re already in a safety role and want to grow into signal detection and aggregate reporting — this programme is built for you.
NHS / Community / Hospital
Pharmacists ready to move into industry
You have the clinical and regulatory instinct. You want the industry translation — GVP, case processing, signal detection, aggregate reports — and a portfolio that shows you can do the work.
BSc / MSc / PhD
Life-science graduates breaking in
Pharmacy, biomedical sciences, pharmacology, toxicology, public health. You understand the science; you need the PV frameworks and hands-on safety output to become hireable.
Drug Safety Associates
In-role professionals levelling up
You already process cases. You want to move into signal detection, PSUR/PBRER authoring, and RMP work — and out of the ICSR-only ceiling. This programme builds the evidence you’re ready for the next band.
Career-Switchers
Science professionals changing direction
Research scientists, lab-based professionals, or clinical-trial adjacent roles who want a structured, compliance-driven industry path with strong long-term prospects.
Alumni Employers
Where PharmaLink graduates work today
Who This Is For
Built for professionals pivoting into pharmacovigilance — not for hobbyists.
PharmaLink's Pharmacovigilance programme is a six-month commitment that changes the trajectory of your career. It isn't for everyone. Here's who gets the most out of it — and who we'd respectfully steer elsewhere.
A good fit if you are
Ready to transition seriously.
- ✓An NHS or community pharmacist, medic or scientist looking for a non-clinical route that still uses your science background.
- ✓A life-science graduate (pharmacy, biomedical, pharmacology, toxicology, public health) wanting your first industry role.
- ✓A mid-career professional in regulatory affairs, QA, medical information or clinical operations who wants to move into pharmacovigilance.
- ✓Comfortable with 8–10 hours per week for six months — evenings, assignments, scenarios.
- ✓Wants portfolio-grade evidence of safety-writing and signal-detection capability by the end — not just a certificate.
Probably not a fit if you're
Looking for something lighter.
- −Looking for a self-paced library of recorded videos. Our sessions are live, twice-weekly and expert-led.
- −Expecting a guaranteed job placement. We back your transition hard; we don't run a recruitment agency.
- −Wanting a one-weekend crash course. Six months is what it actually takes to build the skill.
- −Unable to commit 8–10 hours a week of focused time. The programme genuinely requires it.
- −Already working as a regulatory writer and needing short CPD only. We run separate masterclasses for that.
Next Cohorts
Pick the start that fits your life.
Two cohorts launch every month — 30 seats each — so most applicants are in within six weeks of applying. Live evening sessions 6–8pm.
Opening May cohort — high demand, apply this week to secure your seat.
Early summer cohort. Ideal if you want a few weeks to prepare and wrap up current commitments.
Mid-year cohort. Good choice if you need a longer runway to prepare.
Late-summer cohort. Plan ahead — register early to secure your seat.
Schedule
Once weekly · evenings 6–8pm UK
Cohort size
30 students per cohort
Duration
6 months · 8–10 hrs / week
One last thing
Six months from now you'll either still be thinking about this — or doing it.
Apply now to lock in your seat in the next cohort. If you're still figuring out whether the route is right for you, book a 20-minute discovery call — we'll tell you honestly.
430+ graduates · 69% in pharma-industry roles · £3,999 with payment plans
Frequently Asked
The questions we get most.
Do I need a pharmaceutical or scientific background to apply?
You need a science-based degree or healthcare qualification — pharmacy, medicine, nursing, biomedical sciences, pharmacology, biochemistry, chemistry, or similar. Direct pharma experience isn't required; the programme is designed to build it.
How much time do I need to commit each week?
Plan for 8–10 hours per week across the six months. That covers two live evening sessions (6–8pm), assignments, VIGILANT™ case processing and signal-detection work, and independent reading. The cohort's designed to fit alongside a full-time clinical or other job.
Is the programme accredited?
Yes. The programme is CPD accredited and graduates receive a certificate of completion plus an industry portfolio of real adverse-event cases processed through VIGILANT™ you can use directly in job applications.
What is PharmaLink VIGILANT™, and is it included?
PharmaLink VIGILANT™ is our simulated safety database environment — a live system where you process real adverse-event cases, run signal detection, and produce aggregate reports under realistic pharmacovigilance conditions. It is included in the programme. You work inside VIGILANT™ throughout Tier 1 (case processing foundations) and Tier 2 (signal management, aggregate reporting, inspection readiness), producing portfolio-grade evidence you can show at interview.
What payment options do you offer?
Three options: pay outright at £3,999, three monthly instalments of £1,333, or a 12-month third-party finance plan (subject to eligibility). Eligibility is checked at application. Tier 1 alone (case processing foundations): pay £1,799 outright or 3×£600.
Will I get a job at the end of the programme?
We do not run a recruitment agency, and we don't guarantee placement. What we do guarantee: you finish with a portfolio, a CV positioned for the roles, expert references, and direct help on applications. 69% of our graduates are working in a pharma role within twelve months of completion.
Are sessions recorded if I miss one?
Yes — every live session is recorded and available in your student portal for the duration of the programme and beyond. You also keep lifetime access to the full materials library.
Who teaches the programme?
Sessions are led by pharmacovigilance experts with decades of pharmaceutical industry experience across sponsor-side, CRO and consultancy roles. Phase 2 VIGILANT™ scenarios are observed and debriefed by senior writers and reviewers.
Have a question we haven't answered? Book a 20-minute call →
Join Our Free Trial
Get started today before this once in a lifetime opportunity expires.